Ryan Pearson, PhD, associate professor of pharmaceutical sciences and director of the Bio- and Nano-Technology Center at the University of Maryland School of Pharmacy (UMSOP), has been awarded a prestigious $3.4 million grant from the National Institutes of Health (NIH) to advance groundbreaking research into a first-in-class, cargo-free nanoparticle immunotherapy for the treatment of sepsis.
Sepsis is a life-threatening condition caused by an uncontrolled immune response to infection. According to Pearson’s proposal abstract, sepsis accounts for nearly 20% of all deaths globally, with survivors often suffering long-term health complications such as cardiovascular disease and cognitive impairment. Existing treatments have been hampered by sepsis’ clinical heterogeneity (diversity) and the complexity of its immune dysregulation.
Read the full story on the School of Pharmacy's News Center.